Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Acquired and genetic determinants of disease phenotype and therapeutic strategies in C3 glomerulopathy and immunoglobulin-associated MPGN

13 Nov 2024

Abstract excerpt

C3 glomerulopathy (C3G), a prototype of complement-mediated disease, is characterized by significant heterogeneity, in terms of not only clinical, histological and biological presentation but also prognosis, and response to existing therapies. Recent advancements in understanding the factors responsible for alternative pathway dysregulation in the disease have highlighted its even more complex nature. Here, we...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Coagulation, Bradykinin, Polyphosphates, and Angioedema
Share to Complement system in diseases
Share to Renal Diseases and Glomerulopathies

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39537192
DOI: 10.1093/ndt/gfae245

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Acquired and genetic determinants of disease phenotype and therapeutic strategies in C3 glomerulopathy and immunoglobulin-associated MPGNPMID 39537192Read ↗

C3 Glomerulopathy: A Current Perspective in an Evolving LandscapeSemantic proximity Read ↗

Complement inhibition in C3 glomerulopathy.Semantic proximity Read ↗

C3 glomerulopathy: what's in a name?Semantic proximity Read ↗

C3 Glomerulopathy: Ten Years' Experience at Mayo Clinic.Semantic proximity Read ↗

C3 glomerulopathy: the genetic and clinical findings in dense deposit disease and C3 glomerulonephritis.Semantic proximity Read ↗

Defining Nephritic Factors as Diverse Drivers of Systemic Complement Dysregulation in C3 GlomerulopathySemantic proximity Read ↗

Recent insights into C3 glomerulopathySemantic proximity Read ↗

C3 glomerulopathy: a kidney disease mediated by alternative pathway deregulationSemantic proximity Read ↗

Pathogenesis of the C3 glomerulopathies and reclassification of MPGNSemantic proximity Read ↗

Membranoproliferative glomerulonephritis: no longer the same disease and may need very different treatmentSemantic proximity Read ↗

Defining the Complement Biomarker Profile of C3 GlomerulopathySemantic proximity Read ↗

Genetic and acquired abnormalities in C3 glomerulopathy and primary immune complex-mediated MPGNSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.